Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I've heard similar whispers about shifts within Moderna. It's always unnerving when there's a sense of flux, especially when it's not openly communicated. The R&D sector is so critical to biotech, so any movement there certainly raises eyebrows. Hope those leaving find fulfilling opportunities elsewhere, and that the company can navigate these changes smoothly.
This is concerning to hear. The lack of transparency around departures can create a lot of anxiety for those remaining. Budget reviews and changing priorities are understandable in a dynamic industry, but a steady 'quiet exit' suggests deeper issues might be at play. It'll be interesting to see if any official statements or strategic shifts emerge to address the situation.